Contact the Cancer Biomarkers Research Group

Phone: 240-276-7040

Fax: 240-276-7845

For Regular Mail

Cancer Biomarkers Research Group, DCP

Division of Cancer Prevention National Cancer Institute
9609 Medical Center Drive
MSC 9790
Bethesda, MD 20892-9790
United States

For Courier Packages

Cancer Biomarkers Research Group, DCP

Division of Cancer Prevention National Cancer Institute
9609 Medical Center Drive
Rockville, MD 20850
United States

Funding Opportunities

Title	Announcement Number	Activity Code	Clinical Trials Status Sort descending	Expiration Date	Program Official
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers	NOT-CA-23-004			07/02/2025	Matthew Young, Ph.D.
Assay Validation of High Quality Markers for Clinical Studies in Cancer	PAR-23-314 (UH3 Clinical Trials Not Allowed)	UH3		10/15/2026	Sudhir Srivastava, Ph.D., M.P.H.
Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)	NOT-OD-22-202		Clinical Trial Not Allowed	04/16/2025	Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Notice of Intent to Publish a Funding Opportunity Announcement for Pre-Cancer Atlas (PCA) Research Centers	NOT-CA-23-085 (U01 Clinical Trial Not Allowed)	U01	Clinical Trial Not Allowed	09/01/2024	Indu Kohaar, Ph.D.
Assay Validation of High Quality Markers for Clinical Studies in Cancer	PAR-23-313 (UH2/UH3 Clinical Trial Not Allowed)	UH2, UH3	Clinical Trial Not Allowed	10/15/2026	Sudhir Srivastava, Ph.D., M.P.H.
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research	RFA-CA-24-009 (R33 Clinical Trial Not Allowed)	R33	Clinical Trial Not Allowed	10/02/2024	Guillermo Marquez, Ph.D.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research	RFA-CA-24-008 (R61 Clinical Trial Not Allowed)	R61	Clinical Trial Not Allowed	10/02/2024	Guillermo Marquez, Ph.D.
Pancreatic Cancer Detection Consortium: Research Units	PAR-21-334 (U01 Clinical Trial Optional)	U01	Clinical Trial Optional	06/12/2024
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research	PAR-22-099 (R01 Clinical Trial Optional)	R01	Clinical Trial Optional	05/08/2025	Richard Mazurchuk, Ph.D.
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes	PAR-22-131 (R01 Clinical Trial Optional)	R01	Clinical Trial Optional	09/08/2025	Richard Mazurchuk, Ph.D.